PERSPECTA

News from every angle

Back to headlines

Eli Lilly’s new oral pill outperforms oral semaglutide for blood sugar control and weight loss in trial

27 Feb, 05:49 — 27 Feb, 05:49
PostShare

Sources

Showing 1 of 3 sources